Table 2.

Comparison of echocardiography and tissue Doppler variables at baseline and 6 month of follow-up.

		Placebo	p value	Car (6.25 mg)	p value	Car (12.5 mg)	p value	Car (25 mg)	p value
LVSd	Baseline	28.0 ± 4.4	0.002	29.3 ± 4.4	0.059	29.2 ± 4.2	0.178	30.2 ± 5.7	0.458
	6 months	30.7 ± 5.7		30.4 ± 3.0		30.3 ± 4.3		30.9 ± 4.1
LVDd	Baseline	45.3 ± 5.3	0.566	46.0 ± 5.1	0.166	44.8 ± 4.3	0.011	44.6 ± 6.3	0.368
	6 months	45.9 ± 7.5		46.8 ± 4.0		46.0 ± 3.7		45.5 ± 5.3
EF	Baseline	62.0 ± 4.6	0.002	61.4 ± 3.9	0.059	60.0 ± 4.1	0.100	60.4 ± 4.2	0.073
	6 months	58.2 ± 6.6		60.0 ± 2.9		58.2 ± 6.6		59.2 ± 2.8
E'	Baseline	11.3 ± 3.0	0.365	11.9 ± 3.2	0.067	13.2 ± 5.0	0.001	11.8 ± 3.4	015
	6 months	10.9 ± 3.8		10.9 ± 3.4		11.8 ± 4.9		10.8 ± 3.0
E/A	Baseline	1.22 ± 0.4	0.533	1.20 ± 0.5	0.359	1.26 ± 0.5	0.949	1.17 ± 0.3	0.251
	6 months	1.20 ± 0.4		1.14 ± 0.4		1.27 ± 0.6		1.13 ± 0.3
DT	Baseline	190.7 ± 33.9	0.188	200.8 ± 28.2	0.637	203.6 ± 38.7	0.228	199.5 ± 38.8	0.139
	6 months	199.7 ± 39.8		197.1 ± 30.0		213.3 ± 45.1		209.3 ± 40.9
E/E'	Baseline	7.2 ± 2.6	0.413	7.4 ± 3.0	0.730	7.0 ± 3.3	0.033	6.9 ± 2.6	0.788
	6 months	7.6 ± 3.3		7.6 ± 3.6		8.0 ± 4.0		7.0 ± 2.2

Car* stands for carvedilol.